EPO dose and Hb in 2005–2008 in ten countries [26] and in the study unit (Study) in February–July, 2011.

About this item

Title

EPO dose and Hb in 2005–2008 in ten countries [26] and in the study unit (Study) in February–July, 2011.

Content partner

FigShare

Collection

FigShare

Description

(Abbreviations: ANZ =  Australia and New Zealand; BE =  Belgium; CA =  Canada; Fr =  France; GE =  Germany; IT =  Italy; SP =  Spain; SW =  Sweden; UK =  United Kingdom; US =  United States).

Format

Image

Date created

20 May, 2014

Creator

Jonathan A. Lorch / Victor E. Pollak

URL

https://figshare.com/articles/figure/_EPO_dose_and_Hb_in_2005_2008_in_ten_countries_26_and_in_the...

Related subjects

epidemiology / Disease informatics / health care / Health care policy / Health economics / Long-term care / Medical practice management / Quality of care / hematology / anemia / Iron deficiency anemia / Nephrology / Chronic kidney disease / Medical dialysis / Database and informatics methods / Health informatics / research design / Clinical research design / Comparative effectiveness research / Cohort studies / Longitudinal studies / Observational studies / Prospective studies / Qualitative studies / Economics / Economic analysis / Cost-effectiveness analysis / hb / countries / Biological Sciences / Science Policy

What is the copyright status of this item?

Creative Commons

This item appears to be licensed under a Creative Commons Attribution (BY) CC International license.

More Information

FigShare has this to say about the rights status of this item:

http://figshare.com/licensing

You can learn more about the rights status of this item at: http://creativecommons.org/licenses/by/4.0

What can I do with this item?

You must always check with FigShare to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

Share it

This item is suitable for copying and sharing with others, without further permission.

Modify it

This item is suitable for modifying, remixing and building upon, without further permission.

Use it commercially

This item is suitable for commercial use, without further permission.